# Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.

> **NCT00733551** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 31 (actual)

## Conditions studied

- Gastroparesis

## Interventions

- **DRUG:** GSK962040
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00733551
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-23
- **Primary completion:** 2009-07-20
- **Final completion:** 2009-07-20
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733551, "Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00733551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*